| Cabozantinib studied in …STUDIED_INderived200 of 246show all (up to 200) |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · 246 trials list this drug (104 active) | — | — | Malignant Genitourinary System Neoplasm,Large Cell Neuroendocrine Carcinoma,Sarcomatoid Renal Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04310007Phase 2 · active not recruiting Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer · 246 trials list this drug (104 active) | — | — | Malignant Lung Neoplasm,Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05691478Phase 2/Phase 3 · suspended A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma · 246 trials list this drug (104 active) | — | — | Osteosarcoma,Secondary Osteosarcoma,High Grade Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07011719Phase 3 · recruiting Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04071223Phase 2 · active not recruiting Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study · 246 trials list this drug (104 active) | — | — | Clear Cell Renal Cell Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136196Phase 2 · recruiting BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study · 246 trials list this drug (104 active) | — | — | Melanoma,Malignant Lip and Oral Cavity Neoplasm,Head and Neck Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07194044Phase 1 · recruiting Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes · 246 trials list this drug (104 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05188118early Phase 1 · completed Rapid Sequencing of Approved Therapies in Patients With Metastatic or Unresectable Clear Cell Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05773274Phase 2 · recruiting Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial · 246 trials list this drug (104 active) | — | — | Digestive System Neuroendocrine Tumor G1,Digestive System Neuroendocrine Tumor G2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06475989Phase 3 · recruiting Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer · 246 trials list this drug (104 active) | — | — | Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03816345Phase 1 · recruiting Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO · 246 trials list this drug (104 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899155Phase 2 · recruiting Pan Tumor Rollover Study · 246 trials list this drug (104 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07293351Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07405164Phase 3 · recruiting Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043) · 246 trials list this drug (104 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03375320Phase 3 · active not recruiting Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · 246 trials list this drug (104 active) | — | — | Digestive System Neuroendocrine Neoplasm,Neuroendocrine Neoplasm,Functioning Pancreatic Neuroendocrine Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04079712Phase 2 · active not recruiting Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors · 246 trials list this drug (104 active) | — | — | Neuroendocrine Neoplasm,Neuroendocrine Carcinoma,Large Cell Neuroendocrine Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03635892Phase 2 · active not recruiting A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Papillary Renal Cell Carcinoma,Renal Cell Carcinoma,Collecting Duct Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05904080Phase 2 · suspended Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer · 246 trials list this drug (104 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05048212Phase 2 · recruiting A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases · 246 trials list this drug (104 active) | — | — | Brain Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327686Phase 2 · recruiting Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06900595Phase 2 · recruiting Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer · 246 trials list this drug (104 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04412629Phase 2 · active not recruiting Cabozantinib in High Grade Neuroendocrine Neoplasms · 246 trials list this drug (104 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05012371Phase 2 · active not recruiting Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer · 246 trials list this drug (104 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · 246 trials list this drug (104 active) | — | — | Malignant Genitourinary System Neoplasm,Malignant Solid Neoplasm,Penile Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01708954Phase 2 · active not recruiting Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer · 246 trials list this drug (104 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03367741Phase 2 · active not recruiting Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer · 246 trials list this drug (104 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04339738Phase 2 · active not recruiting Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma · 246 trials list this drug (104 active) | — | — | Skin Angiosarcoma,Skin Radiation-Related Angiosarcoma,Visceral Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05502315Phase 2 · active not recruiting Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer · 246 trials list this drug (104 active) | — | — | Malignant Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05411081Phase 2 · active not recruiting Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial · 246 trials list this drug (104 active) | — | — | Papillary Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06156410Phase 1 · recruiting Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas · 246 trials list this drug (104 active) | — | — | Sarcoma,Ewing Sarcoma,Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06811116Phase 1/Phase 2 · recruiting Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03793166Phase 3 · active not recruiting Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study · 246 trials list this drug (104 active) | — | — | Rhabdoid Tumor of the Kidney,Sarcomatoid Renal Cell Carcinoma,Clear Cell Renal Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05536141Phase 1 · recruiting A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors · 246 trials list this drug (104 active) | — | — | Solid Neoplasm,Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07077161Phase 2 · recruiting Cabozantinib Dose Skipping as an Alternative to Dose Reductions · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · 246 trials list this drug (104 active) | — | — | Solid Neoplasm,Central Nervous System Neoplasm,Hepatoblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05039281Phase 1/Phase 2 · active not recruiting Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma · 246 trials list this drug (104 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03141177Phase 3 · completed A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06502171Phase 1 · recruiting Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas · 246 trials list this drug (104 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05361720Phase 2 · recruiting Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study · 246 trials list this drug (104 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02243605Phase 2 · active not recruiting Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma · 246 trials list this drug (104 active) | — | — | Ewing Sarcoma,Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620574Phase 3 · enrolling by invitation Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study · 246 trials list this drug (104 active) | — | — | Malignant Neoplasm,Hepatocellular Carcinoma,Pancreatic Neuroendocrine Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05613894Phase 1 · recruiting Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer · 246 trials list this drug (104 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07187869Phase 1 · recruiting Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study · 246 trials list this drug (104 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01639508Phase 2 · recruiting Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity · 246 trials list this drug (104 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05111574Phase 2 · active not recruiting Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery · 246 trials list this drug (104 active) | — | — | Head and Neck Mucosal Melanoma,Vulvar Melanoma,Esophageal Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05168163Phase 2 · recruiting Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227402Phase 3 · recruiting A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914300Phase 2 · active not recruiting Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer · 246 trials list this drug (104 active) | — | — | Thyroid Gland Follicular Carcinoma,Thyroid Gland Oncocytic Carcinoma,Differentiated Thyroid Gland Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03945773Phase 2 · completed Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04205799Phase 2 · completed Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure · 246 trials list this drug (104 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05663710Phase 1/Phase 2 · recruiting Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC · 246 trials list this drug (104 active) | — | — | Malignant Neoplasm,Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05263050Phase 2 · recruiting Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors · 246 trials list this drug (104 active) | — | — | Neuroendocrine Tumor,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03768063Phase 3 · active not recruiting A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study · 246 trials list this drug (104 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04413123Phase 2 · active not recruiting Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC · 246 trials list this drug (104 active) | — | — | Papillary Renal Cell Carcinoma,Renal Cell Carcinoma,Collecting Duct Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04164979Phase 2 · completed Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma · 246 trials list this drug (104 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541902Phase 2 · active not recruiting Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Sarcomatoid Renal Cell Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092373Phase 1 · recruiting Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax · 246 trials list this drug (104 active) | — | — | Malignant Abdominal Neoplasm,Malignant Solid Neoplasm,Malignant Thoracic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04116541Phase 2 · recruiting A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors. · 246 trials list this drug (104 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05127824Phase 2 · recruiting Autologous Dendritic Cell Vaccine in Kidney Cancer · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04472767Phase 2 · recruiting Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06835972Phase 1/Phase 2 · recruiting A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC) · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092958Phase 3 · active not recruiting Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study · 246 trials list this drug (104 active) | — | — | Renal Pelvis and Ureter Carcinoma,Bladder Urothelial Carcinoma,Malignant Bladder Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07383441Phase 3 · recruiting Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer · 246 trials list this drug (104 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06026410Phase 1 · recruiting KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors · 246 trials list this drug (104 active) | — | — | Lung Non-Small Cell Carcinoma,Clear Cell Renal Cell Carcinoma,Malignant Colorectal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04322955Phase 2 · active not recruiting CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition · 246 trials list this drug (104 active) | — | — | Malignant Kidney Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05168618Phase 2 · recruiting Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer · 246 trials list this drug (104 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04514484Phase 1 · active not recruiting Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV · 246 trials list this drug (104 active) | — | — | Malignant Solid Neoplasm,Melanoma,Head and Neck Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03611595Phase 1 · completed Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors · 246 trials list this drug (104 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05425004Phase 2 · recruiting Cabozantinib for Patients With Recurrent or Progressive Meningioma · 246 trials list this drug (104 active) | — | — | Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05038839Phase 1 · completed Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors · 246 trials list this drug (104 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04022343Phase 2 · active not recruiting Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer · 246 trials list this drug (104 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04586231Phase 3 · active not recruiting A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011) · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05660954Phase 2 · completed Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer. · 246 trials list this drug (104 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04200443Phase 2 · active not recruiting Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma · 246 trials list this drug (104 active) | — | — | Soft Tissue Sarcoma,Leiomyosarcoma,Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04631744Phase 2 · terminated Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) · 246 trials list this drug (104 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04878029Phase 1 · recruiting Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer · 246 trials list this drug (104 active) | — | — | Urothelial Carcinoma,Invasive Bladder Urothelial Carcinoma with Squamous Differentiation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04868773Phase 1 · completed Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy · 246 trials list this drug (104 active) | — | — | Malignant Neoplasm,Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05836571Phase 2 · active not recruiting Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma · 246 trials list this drug (104 active) | — | — | Liposarcoma,Soft Tissue Sarcoma,Extraskeletal Myxoid Chondrosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05019703Phase 2 · recruiting Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study · 246 trials list this drug (104 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04416646completed Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05249114Phase 1 · active not recruiting Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors · 246 trials list this drug (104 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05048901Phase 1/Phase 2 · recruiting Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors · 246 trials list this drug (104 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03798626Phase 1 · completed Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers · 246 trials list this drug (104 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04963283Phase 2 · active not recruiting Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer · 246 trials list this drug (104 active) | — | — | Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm,Colon Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06341712Phase 2 · terminated Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma · 246 trials list this drug (104 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04211337Phase 3 · active not recruiting A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer · 246 trials list this drug (104 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04338269Phase 3 · terminated A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05122546Phase 1 · active not recruiting CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer · 246 trials list this drug (104 active) | — | — | Sarcomatoid Renal Cell Carcinoma,Clear Cell Renal Cell Carcinoma,Papillary Renal Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04588051Phase 2 · active not recruiting Cabozantinib in Hepatocellular Carcinoma · 246 trials list this drug (104 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04091750Phase 2 · active not recruiting Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma · 246 trials list this drug (104 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01068782Phase 2 · terminated Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse · 246 trials list this drug (104 active) | — | — | Astrocytic Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06006013Phase 2 · recruiting Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer · 246 trials list this drug (104 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06716853Phase 1/Phase 2 · terminated A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03957551Phase 1/Phase 2 · terminated Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma · 246 trials list this drug (104 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03468218Phase 2 · active not recruiting Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer · 246 trials list this drug (104 active) | — | — | Head and Neck Carcinoma,Head and Neck Squamous Cell Carcinoma,Laryngeal Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03539822Phase 1/Phase 2 · recruiting Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies · 246 trials list this drug (104 active) | — | — | Malignant Gastric Neoplasm,Hepatocellular Carcinoma,Esophageal Adenocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04876456Phase 2 · active not recruiting A Phase II Trial of Cabozantinib With Patients With Refractory GCTs · 246 trials list this drug (104 active) | — | — | Germ Cell Tumor,Ovarian Germ Cell Tumor,Seminoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00596648Phase 1/Phase 2 · completed A Study of XL184 (Cabozantinib) With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer (NSCLC) · 246 trials list this drug (104 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01995058Phase 2 · terminated Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC · 246 trials list this drug (104 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05613413Phase 2 · recruiting A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC) · 246 trials list this drug (104 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05100082completed Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01658878Phase 1/Phase 2 · completed An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04471428Phase 3 · completed Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy · 246 trials list this drug (104 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04446117Phase 3 · active not recruiting Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC · 246 trials list this drug (104 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03755791Phase 3 · active not recruiting Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04204850Phase 2 · recruiting Cabozantinib to Treat Recurrent Liver Cancer Post Transplant · 246 trials list this drug (104 active) | — | — | Malignant Neoplasm,Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05052723Phase 2 · completed Cabozantinib and Pembrolizumab in Metastatic Pancreas · 246 trials list this drug (104 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06132945Phase 1 · active not recruiting A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain · 246 trials list this drug (104 active) | — | — | Brain Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04477512Phase 1 · completed Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial) · 246 trials list this drug (104 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04551430Phase 2 · active not recruiting Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma · 246 trials list this drug (104 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05931393Phase 2 · recruiting Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC) · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935934Phase 2 · completed Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · 246 trials list this drug (104 active) | — | — | Endometrioid Adenocarcinoma,Uterine Corpus Carcinosarcoma,Endometrial Serous Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03690388Phase 3 · active not recruiting A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy · 246 trials list this drug (104 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06934057Phase 4 · recruiting Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Malignant Kidney Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03937219Phase 3 · active not recruiting Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07151326Phase 2 · not yet recruiting Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01896479Phase 4 · active not recruiting A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer · 246 trials list this drug (104 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03170960Phase 1 · active not recruiting Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors · 246 trials list this drug (104 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Gastric Neoplasm,Hepatocellular Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05135975Phase 2 · recruiting A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors · 246 trials list this drug (104 active) | — | — | Sarcoma,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03685448Phase 2 · completed ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) · 246 trials list this drug (104 active) | — | — | Sarcomatoid Renal Cell Carcinoma,Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03967522Phase 2 · completed Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01979393Phase 2 · completed IRCI Gynae Sarcomas, High Grade Uterine Sarcoma · 246 trials list this drug (104 active) | — | — | Uterine Corpus Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02302833Phase 2 · completed Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery · 246 trials list this drug (104 active) | — | — | Paraganglioma,Adrenal Gland Pheochromocytoma,Regional Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04220229Phase 1/Phase 2 · terminated Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities · 246 trials list this drug (104 active) | — | — | Sarcoma of the Extremity,Soft Tissue Sarcoma of the Trunk and Extremities | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05797805Phase 1/Phase 2 · recruiting A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04400474Phase 2 · completed Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study · 246 trials list this drug (104 active) | — | — | Adenocarcinoma,Neuroendocrine Tumor,Paraganglioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07010393Phase 4 · not yet recruiting Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study · 246 trials list this drug (104 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01441947Phase 2 · completed Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer · 246 trials list this drug (104 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04804813completed Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04316182Phase 2 · completed Cabozantinib in Patients With Hepatocellular Carcinoma (ACTION) · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899428Phase 2 · recruiting Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03149822Phase 1/Phase 2 · completed Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04197310Phase 2 · completed Cabozantinib and Nivolumab for Carcinoid Tumors · 246 trials list this drug (104 active) | — | — | Neuroendocrine Tumor,Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04511455Phase 2 · completed Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line Treatment · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04522908Phase 2 · completed Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Preserved Liver Function · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04767906Phase 2 · completed Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06364631Phase 3 · recruiting CARE1 Pragmatic Clinical Trial · 246 trials list this drug (104 active) | — | — | Malignant Kidney Neoplasm,Kidney Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02761057Phase 2 · completed Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed · 246 trials list this drug (104 active) | — | — | Papillary Renal Cell Carcinoma,Renal Cell Carcinoma,Type 1 Papillary Renal Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007613Phase 2 · completed Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Malignant Neoplasm,Malignant Esophageal Neoplasm,Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03634540Phase 2 · active not recruiting A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) · 246 trials list this drug (104 active) | — | — | Malignant Kidney Neoplasm,Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03370718Phase 2 · completed Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma · 246 trials list this drug (104 active) | — | — | Adrenal Cortical Carcinoma,Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06482086Phase 2 · recruiting Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer · 246 trials list this drug (104 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04289779Phase 2 · active not recruiting Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer · 246 trials list this drug (104 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03534804Phase 2 · completed Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma · 246 trials list this drug (104 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05200143Phase 2 · terminated Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma · 246 trials list this drug (104 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03299946Phase 1 · completed Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC) · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03612232Phase 2 · unknown Cabozantinib in Advanced Adrenocortical Carcinoma · 246 trials list this drug (104 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04524208Phase 2 · unknown A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3 · 246 trials list this drug (104 active) | — | — | Neuroendocrine Carcinoma,Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06548867unknown Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04497038Phase 1/Phase 2 · terminated Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy · 246 trials list this drug (104 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06535737Phase 2 · not yet recruiting A Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and Bevacizumab · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05265988Phase 2 · completed Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib · 246 trials list this drug (104 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03667482Phase 1 · completed Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer · 246 trials list this drug (104 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03200587Phase 1 · completed Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC) · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293980Phase 1 · active not recruiting A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) · 246 trials list this drug (104 active) | — | — | Malignant Kidney Neoplasm,Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05859217Phase 2 · not yet recruiting A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1) · 246 trials list this drug (104 active) | — | — | Lung Neoplasm,Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06377722Phase 2 · terminated Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00940225Phase 2 · completed Study of Cabozantinib (XL184) in Adults With Advanced Malignancies · 246 trials list this drug (104 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01466036Phase 2 · completed Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · 246 trials list this drug (104 active) | — | — | Neuroendocrine Tumor,Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02592356NA · completed Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer · 246 trials list this drug (104 active) | — | — | Thyroid Gland Medullary Carcinoma,Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 246 trials list this drug (104 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04540705Phase 1 · completed A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00704288Phase 2 · completed Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme · 246 trials list this drug (104 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02925234Phase 2 · recruiting The Drug Rediscovery Protocol (DRUP Trial) · 246 trials list this drug (104 active) | — | — | Neoplasm,Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04134390Phase 2 · completed Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR Study · 246 trials list this drug (104 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04760288Phase 3 · withdrawn A Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MTC). · 246 trials list this drug (104 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01755195Phase 2 · completed Cabozantinib for Adults With Advanced Soft Tissue Sarcoma · 246 trials list this drug (104 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06171854Phase 2 · unknown caBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer. · 246 trials list this drug (104 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01709435Phase 1 · completed Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors · 246 trials list this drug (104 active) | — | — | Malignant Solid Neoplasm,Melanoma,Primary Central Nervous System Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04151563Phase 1/Phase 2 · withdrawn A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy · 246 trials list this drug (104 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02795156Phase 2 · completed Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations · 246 trials list this drug (104 active) | — | — | Lung Non-Small Cell Carcinoma,Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04300140Phase 1/Phase 2 · terminated Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03468985Phase 2 · completed Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer · 246 trials list this drug (104 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03201250Phase 1/Phase 2 · terminated Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma · 246 trials list this drug (104 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101736Phase 2 · completed Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults · 246 trials list this drug (104 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05039736Phase 2 · withdrawn A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma,Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02036476Phase 2 · terminated Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Malignant Skin Neoplasm,Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03586973Phase 2 · completed A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03729245Phase 3 · terminated A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04442581Phase 2 · terminated Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma,BCLC Stage B Hepatocellular Carcinoma,BCLC Stage C Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03428217Phase 2 · completed CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04661852Phase 1 · completed Cabozantinib With Topotecan-Cyclophosphamide · 246 trials list this drug (104 active) | — | — | Ewing Sarcoma,Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01822522Phase 1 · completed Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus · 246 trials list this drug (104 active) | — | — | Solid Neoplasm,Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327738Phase 2 · withdrawn Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma · 246 trials list this drug (104 active) | — | — | Hepatocellular Carcinoma,BCLC Stage B Hepatocellular Carcinoma,BCLC Stage C Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04510688completed Spanish Real-World Evidence Cabozantinib · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01688999Phase 2 · completed Cabozantinib for Advanced Urothelial Cancer · 246 trials list this drug (104 active) | — | — | Bladder Neoplasm,Kidney Neoplasm,Urethra Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02885324Phase 2 · terminated Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children · 246 trials list this drug (104 active) | — | — | Anaplastic Astrocytoma,Glioblastoma,Malignant Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01835145Phase 2 · completed Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery · 246 trials list this drug (104 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03542877Phase 2 · completed Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer · 246 trials list this drug (104 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03964337Phase 2 · terminated Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer · 246 trials list this drug (104 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04173338Phase 1 · terminated Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma · 246 trials list this drug (104 active) | — | — | Malignant Mesothelioma,Lung Non-Small Cell Carcinoma,Urothelial Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05241561Phase 2 · not yet recruiting Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients · 246 trials list this drug (104 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01630590Phase 2 · completed Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer · 246 trials list this drug (104 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03239015Phase 2 · unknown Efficacy and Safety of Precision Therapy in Refractory Tumor · 246 trials list this drug (104 active) | — | — | Neoplasm,Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03316586Phase 2 · completed A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer · 246 trials list this drug (104 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02041260Phase 2 · unknown A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting · 246 trials list this drug (104 active) | — | — | Poorly Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03339219Phase 2 · completed A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma · 246 trials list this drug (104 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04427787Phase 2 · unknown A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET · 246 trials list this drug (104 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04066595Phase 2 · terminated Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma. · 246 trials list this drug (104 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01574937Phase 1 · completed XL-184+Abiraterone in Post-Chemo CRPC · 246 trials list this drug (104 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |